Rotblat, B., Mock, A., Fayette, J., Cohen, L., Cohen, I., Voronov, E., . . . Elkabets, M. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRotblat, Barak, et al. MEK1/2 Inhibition Transiently Alters the Tumor Immune Microenvironment to Enhance Immunotherapy Efficacy Against Head and Neck Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationRotblat, Barak, et al. MEK1/2 Inhibition Transiently Alters the Tumor Immune Microenvironment to Enhance Immunotherapy Efficacy Against Head and Neck Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.